MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -57.5% | 24,067 | +8.5% | 0.00% | – |
| Q2 2023 | $73 | -27.7% | 22,187 | -9.8% | 0.00% | -100.0% |
| Q1 2023 | $101 | -26.8% | 24,589 | +4.1% | 0.00% | 0.0% |
| Q4 2022 | $138 | -99.9% | 23,612 | -7.5% | 0.00% | 0.0% |
| Q3 2022 | $172,000 | +266.0% | 25,514 | +114.4% | 0.00% | – |
| Q1 2022 | $47,000 | -29.9% | 11,902 | +10.0% | 0.00% | – |
| Q4 2021 | $67,000 | -96.6% | 10,819 | -91.2% | 0.00% | -100.0% |
| Q1 2021 | $1,989,000 | -45.5% | 122,938 | -10.4% | 0.01% | -50.0% |
| Q4 2020 | $3,649,000 | +41.9% | 137,141 | -0.7% | 0.02% | +29.4% |
| Q3 2020 | $2,571,000 | – | 138,097 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |